Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lithospermum cream is a topical herbal formulation derived from the root of *Lithospermum erythrorhizon* (known as Zicao in Traditional Chinese Medicine). It is primarily used for its anti-inflammatory, antioxidant, and wound-healing properties. The therapeutic effects are largely attributed to shikonin and its derivatives, which are naphthoquinone compounds that modulate inflammatory pathways. In clinical settings, it is being investigated as a treatment for hormone-dependent dermatitis (HDD), a condition resulting from the long-term misuse of topical corticosteroids. The cream serves as a non-steroidal alternative to agents like pimecrolimus, helping to alleviate symptoms such as erythema, burning, and itching while promoting the restoration of the skin barrier.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lithospermum cream.